COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

NEW YORK MEDICAL CANNABIS INDUSTRY ASSOC
ALBANY, NY · EIN 821950075 · Form 990 · FY2024 · NTEE S41 · Community Improvement · Small ($100K-$1M) · protectnymedmar.com
revenue
$685K
expenses
$647K
net assets
$405K
employees
0
mission · from form 990

THE INDUSTRY ASSOCIATION WAS FORMED AS AN ENTITY TO SAFEGUARD THE TRADE INTERESTS OF MEMBERS AND ENCOURAGE DIALOGUE AND COLLABORATION AMONG NEW YORK STATE'S REGISTERED ORGANIZATIONS AND TO ADVOCATE ON REGULATORY AND LEGISLATIVE MATTERS PERTAINING TO THE STATE'S MEDICAL MARIJUANA PROGRAM. THE EFFORTS OF THE ASSOCIATION WILL INCLUDE EDUCATING THE PUBLIC, MEDICAL PROFESSIONALS AND LAWMAKERS ON THE LEGAL MEDICAL USES OF MARIJUANA. 100% OF THE ASSOCIATION'S TIME WILL BE SPENT IN THIS ACTIVITY.

profile · synthesized from sources

The New York Medical Cannabis Industry Association (NYMCIA) is a trade association representing medical and adult-use cannabis operators in New York State. It advocates for regulatory and legislative policies supporting a responsible, inclusive, and competitive cannabis industry, while also educating the public, medical professionals, and policymakers about medical cannabis. The organization is composed of major cannabis companies operating in New York.

irs program accomplishments · form 990 part iii · fy2024

What they reported doing

  1. #1 primary $0
    THE ORGANIZATION ADVOCATES ON MATTERS PERTAINING TO NEW YORK'S STATE-LICENSED ADULT-USE CANNABIS INDUSTRY.
named programs · 2 · from sources

What they call their work

Policy Advocacy
Advocates on regulatory and legislative matters related to New York's medical and adult-use cannabis programs, representing member interests to state agencies and lawmakers.
Public and Professional Education
Provides education to the public, medical professionals, and policymakers about the legal medical uses of cannabis and best practices in the industry.
activities · 5 groups

What they do

  • Substance Use Policy Advocacy & Public Education 1 activity
    • Advocacy for legislative and regulatory reforms in New York's cannabis programs
      Advocates for changes to state laws and regulations governing both medical and adult-use cannabis, including supporting the Compassionate Care Act, the Marijuana Regulation and Taxation Act, social equity licensing, and reforms to licensing fees and program implementation. Engages with the Office of Cannabis Management and other state entities to influence policy.
  • Organizational Newsletter Production and Distribution 1 activity
    • Production and distribution of cannabis policy and program updates
      Produces and distributes a monthly newsletter that informs stakeholders about developments in New York's medical and adult-use cannabis programs.
  • Direct Financial Assistance to Individuals 1 activity
    • Provision of compassionate care financial assistance to patients
      Provides direct financial aid to economically disadvantaged patients and veterans in New York to support access to medical cannabis, having distributed nearly $500,000 in assistance.
  • Healthcare Policy Advocacy 1 activity
    • Support for medical cannabis program infrastructure and patient care continuity
      Advocates for the establishment of the Medical Cannabis Ambassador Program and Medical Cannabis Advisory Council to improve accessibility and ensure continuity of care for medical cannabis patients.
  • Uncategorized 4 activities
    • Capacity building in cannabis product formulation and manufacturing
      Develops advanced cannabis product formulation methods that exceed traditional U.S. pharmaceutical manufacturing standards, contributing to industry best practices.
    • Participation in state enforcement actions against illicit cannabis operations
      Participated in state-led efforts that resulted in the seizure of over 8,500 pounds of illicit cannabis products valued at more than $42 million.
    • Research on public health and safety standards in New York's cannabis industry
      Conducts investigations into public health risks in the legal cannabis market, including microbial contamination in top-selling products, failures in lab testing, and the impact of outdoor-only cultivation policies. Documents violations by state-certified laboratories in reporting contaminants.
    • Support for social equity and conditional licensing in cannabis
      Advocates for the prioritization of applicants with prior marijuana convictions in New York’s cannabis licensing process, including support for the codification of the conditional cannabis licensing program and broader social equity mandates within the adult-use program.
financials · form 990 · fy2024
revenue
Total revenue$685K
Contributions & grants$00%
Program service revenue$685K100%
Investment income$00%
Other revenue$0
expenses
Total expenses$647K
Program expenses—
Admin / overhead—
Fundraising—
Salaries & benefits$0
Grants paid out$7K
Largest expense lineProfessional Fees
balance sheet
Total assets$419K
Cash$69K
Investments$0
Liabilities$14K
Net assets$405K
Liquid reserves1.3 mo
4 years on record · 2020–2024 · YoY revenue +20.7%
leadership · form 990 part vii · fy2024

Who runs it

board members · 5
  • DON WILLIAMS — CHAIR
  • JEREMY UNRUH — VICE CHAIR
  • KELLIE RIVERA — VICE CHAIR
  • LYNSI SHECKLER — TREASURER
  • REBECCA BROWN — SECRETARY
relationships · 27

Who they work with

  • Cannabis Control Board Government — Interacts with the Cannabis Control Board through executive intervention to influence licensing decisions.
  • Cannabis Control Board Government — Recognizes and supports policy actions taken by the Cannabis Control Board to enhance medical cannabis accessibility.
  • Cannabis Control Board Government — Recognizes the Cannabis Control Board as the overseeing body for cannabis regulation in New York and supports its role in implementing social equity policies.
  • Cannabis Insider Partner — Referenced investigative report used to support advocacy for improved cannabis lab testing standards.
  • Canopy USA Network — Member organization of NYMCIA
  • Cresco Labs Network — Member organization of NYMCIA
  • Curaleaf Network — Member organization of NYMCIA
  • Department of Taxation and Finance Government — Partners with state enforcement agencies to combat illegal cannabis sales
  • Green Thumb Industries Network — Member organization of NYMCIA
  • LoHud Partner — Publishes opinion articles and news related to the association's advocacy efforts.
  • New York Cannabis Retail Association Partner — Collaborates with the Cannabis Retail Association on advocacy to advance social equity-centered cannabis licensing.
  • New York Department of Health Government — Interacts with regulatory authorities responsible for implementing the medical cannabis program.
  • New York State Cannabis Control Board Government — Works with the state regulatory board on cannabis licensing and policy implementation
  • New York State Legislature Government — Engages with state lawmakers to influence cannabis policy and regulation.
  • Office of Cannabis Management Government — Collaborates with and acknowledges actions taken by the Office of Cannabis Management to improve medical cannabis access.
  • Office of Cannabis Management Government — Collaborates with and refers stakeholders to the Office of Cannabis Management for regulatory updates and licensing information.
  • Office of Cannabis Management Government — Collaborates with state agencies on enforcement and licensing initiatives
  • Office of Cannabis Management Government — Engages with the Office of Cannabis Management, the state agency responsible for regulating medical and adult-use cannabis, in discussions about public health standards.
  • Office of Cannabis Management Government — Engages with the state agency responsible for managing the retail cannabis sales system in New York.
  • Office of Cannabis Management Government — Engages with the state regulator in advocacy efforts to codify the conditional cannabis licensing program.
  • Office of Cannabis Management Government — Works with the Office of Cannabis Management to advocate for the expansion of medical cannabis dispensaries.
  • Office of Cannabis Management Government — Works with the state regulator to shape cannabis licensing policy and regulations in New York.
  • Pharmacann Network — Member organization of NYMCIA
  • The Cannabist Company Network — Member organization of NYMCIA
  • Times Union Partner — Cross-publishes or references articles related to advocacy efforts for cannabis licensing reform.
  • True Labs for Cannabis Partner — Collaborates with or cites findings from True Labs for Cannabis, a New Jersey-based cannabis testing company, to validate safety concerns.
  • iAnthus Network — Member organization of NYMCIA
strategies · 5

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Equity-Driven Regulatory Reform
    methodology: regulatory-reform-for-equity
    By reforming cannabis regulations to reduce barriers for medical operators and prioritize social equity entrepreneurs, we produce a more just and sustainable legal market because inclusive access to licensing corrects historical harms and strengthens community reinvestment.
  • Executive Intervention for Market Stability
    methodology: executive-intervention
    By applying pressure on executive leadership to align agencies and accelerate licensing, we produce faster implementation of equitable cannabis programs because bureaucratic inertia is overcome through top-down coordination and political accountability.
  • Medical-to-Adult-Use Market Transition Model
    methodology: medical-to-adult-use pathway
    By positioning medical cannabis operators as leaders in launching the adult-use market, we produce a safer, more equitable, and economically viable industry because these licensed entities have proven compliance, quality control, and community trust built through patient care.
  • Patient-Centered Policy Advocacy
    methodology: patient-centered advocacy
    By centering patient needs and quality-of-life outcomes in cannabis policy reform, we produce more humane and effective regulations because medical users are the most vulnerable and ethically compelling stakeholders in the cannabis ecosystem.
  • Trade Advocacy with Stakeholder Education
    methodology: trade-advocacy-and-stakeholder-education
    By advancing industry interests through coordinated advocacy and education of policymakers, medical professionals, and the public, we produce regulatory stability and market growth because informed stakeholders are more likely to support evidence-based, sustainable cannabis policies.